COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB11580Ravulizumab3Recruiting1